BNP/CALL/STRYKER CORP./280/0.1/20.12.24 Share Price

Warrant

DE000PN38H13

Market Closed - Deutsche Boerse AG 01:20:24 29/06/2024 am IST
6.54 EUR -0.30% Intraday chart for BNP/CALL/STRYKER CORP./280/0.1/20.12.24
Current month+0.62%
1 month+0.46%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 6.54 -0.30%
27/24/27 6.56 -0.46%
26/24/26 6.59 +3.45%
25/24/25 6.37 -2.00%
24/24/24 6.5 -3.56%

Delayed Quote Deutsche Boerse AG

Last update June 29, 2024 at 01:20 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN38H1
ISINDE000PN38H13
Date issued 02/06/2023
Strike 280 $
Maturity 20/12/2024 (174 Days)
Parity 10 : 1
Emission price 3.84
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.75
Lowest since issue 2.47
Spread 0.05
Spread %0.75%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus